Drug factory · FDA FEI 3000215693

TransOx, Inc.

3469 Leaphart Rd., West Columbia, SC, United States

United States: 1

Serious problems, FDA action at FDA's last inspection, Nov 20, 2014.

Official Action Indicated: inspectors found significant problems and FDA recommended regulatory action, such as a warning letter or import alert.

1 drug inspection on record since 2014: 0 with no problems, 0 with problems fixed voluntarily, 1 with FDA action.

What it does, for whom

DrugRoleForNDC
OxygenMakes it TransOx, Inc. 63144-001

FDA inspection history

EndedResultProgramProblems noted
Nov 20, 2014Serious problems, FDA actionDrug Quality Assurance—

Registered with FDA for: manufacture.